Abstract:
PROBLEM TO BE SOLVED: To provide new semi-synthesized macrolides having antibacterial activity, a pharmaceutical composition including these compounds, and a medical treatment method of remedy.SOLUTION: There is provided a 6-O-substituted erythromycin ketolide derivative expressed by formula (IV-A), where in formula, Rc is hydrogen or a hydroxy-protective group; R is a substituted methyl group; A, B, D and E are each selected from hydrogen, a 1-6C alkyl which may be substituted by a substituent, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocycloalkyl, hydroxy, 1-6C alkoxy, and halogen of Br, Cl, F or I, or the like, under conditions that at least two of A, B, D and E are both hydrogen.
Abstract:
PROBLEM TO BE SOLVED: To provide antibacterial compounds. SOLUTION: Antibacterial compounds represented by formula (II), pharmaceutically acceptable salts, esters or prodrugs thereof, medicinal compositions including the same, methods for treating bacterial infections by administration of such compounds and a method for producing the compound are provided. COPYRIGHT: (C)2010,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a new semisynthesized macrolide having antibacterial activity.SOLUTION: The antibacterial compound having formula (II) or the like, and pharmaceutically acceptable salts, esters or prodrugs thereof, are provided. Pharmaceutical compositions each containing such a compound; methods for treating bacterial infections by administering such a compound; and a method for producing the compound; are also provided.
Abstract:
PROBLEM TO BE SOLVED: To obtain a new compound for inhibiting a retrovirus protease, especially inhibiting a human immunodeficiency virus(HIV) protease. SOLUTION: This retrovirus inhibitory compound is represented by the formula: A-X-B, specifically a compound in which A is 5-thiazolyl group; X is carbonatomethyl group; and B is p-nitrophenyl group). A composition for inhibiting the retrovirus protease is obtained and a method for inhibiting the retrovirus protease is provided. A composition for treating the HIV infection is obtained and a method for treating the HIV infection is provided. A method and an intermediate effective for producing the retrovirus protease inhibitor are provided.
Abstract:
PROBLEM TO BE SOLVED: To provide novel semi-synthetic macrolides having antibacterial activity and pharmaceutical compositions containing these compounds and to provide medical methods for treating bacterial infection. SOLUTION: Antimicrobial compounds having formula (III) as well as pharmaceutically acceptable salts, esters or prodrugs thereof are provided herein. COPYRIGHT: (C)2010,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a new antibacterial compound with enhanced activity. SOLUTION: Antibacterial compounds represented by formula (II) or the like, pharmaceutically acceptable salts, esters or prodrugs thereof, medicinal compositions including the same, treatment methods for bacterial infections by administration of such compounds and a method for producing the compound are provided. COPYRIGHT: (C)2009,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a medicine for bacterial infection. SOLUTION: The invention relates to the compounds represented by formula (IV) in the specification. COPYRIGHT: (C)2009,JPO&INPIT
Abstract:
PROBLEM TO BE SOLVED: To provide a new class 6-O-substituted erythromycin derivative having increased acid stability to erythromycin A and 6-O-methylerythromycin A, and enhanced activity to gram-negative bacteria and macrolide-resisting gram-positive bacteria. SOLUTION: Provided are an antibacterial compound having structural formula (V) and the like as well as pharmaceutically permissible salts, esters or prodrugs thereof; pharmaceutical compositions comprising the compound; a therapeutic method of bacterial infection by administering the compound; and a production method of the compound. COPYRIGHT: (C)2009,JPO&INPIT
Abstract:
A method for treating tumors and macular degeneration in a human or veterinary patient comprising administering a compound selected from the group consisting of (I), (II), (III), (IV), (V), (VI), (VII), and a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound thereof.